How to Absolutely NAIL the Management of an FDA Inspection.

How to Absolutely NAIL the Management of an FDA Inspection: Starting With the First 60 Minutes

Written by a former FDA Investigator who spent 14 years issuing Form FDA-483s, then 13 years as a pharmaceutical quality executive, including work navigating J&J out of consent decree.

Most companies prepare for months and then lose the inspection in the first hour without realizing it. The document review that follows doesn't determine the outcome. It confirms what the Investigator already concluded during the opening meeting and the facility walk.

[This is an employer-reimbursable professional compliance resource. Send this page to your Quality Director, Site Head, Regulatory Affairs leader or Learning and Development department for approval.]

This is a comprehensive, field-tested breakdown of exactly what happens, and what should happen on your side, in that critical first 60 minutes:

• Why the opening meeting is the Investigator's first live test of management control, and who actually belongs in the room (hint: not eight people)
• How to select and prepare the right inspection escort, including a from-the-field breakdown of what over-talking costs you
• What the facility walkthrough is really scanning for, the concept of "mismatch" between paperwork and reality, and the specific physical details experienced Investigators are trained to notice
• Why secondary spaces (gowning rooms, staging areas, reject cages) reveal more than your polished production floor
• The soft-skill dynamics that change inspection outcomes: what hospitality is appropriate, what crosses an ethics line, and why document delivery is the highest-value courtesy you can offer
• How to read an Investigator's communication style (document-driven, conversational, or technical) and adapt your team's delivery without changing a single fact
• A full document-room operating system: pre-staged EIR profile data, a ready-before-asked document checklist by category, role assignments, and a request-tracking log structure
• Why volunteered information, speculative language, and minimizing phrases ("that was just a minor issue") create inspection pathways you didn't need to open
• A structured 60-minute internal debrief protocol your leadership team should run while the Investigator is still on site, including what to review, who should be in the room, and how to catch statement-to-record mismatches before FDA does

This is not textbook compliance. It is the pattern intelligence that only comes from having sat on both sides of that conference room table, built into a practical operating framework your team can run before your next inspection.

For informational purposes only. Does not constitute legal advice.